BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 3003037)

  • 1. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Bergman H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000203. PubMed ID: 29663328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic medication for antipsychotic-induced tardive dyskinesia.
    Tammenmaa-Aho I; Asher R; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000207. PubMed ID: 29553158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J; Ogawa Y; Shinohara K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000208. PubMed ID: 29552749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate for schizophrenia.
    Wang Y; Xia J; Helfer B; Li C; Leucht S
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD004028. PubMed ID: 27884042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of choline and lecithin in the treatment of tardive dyskinesia.
    Zeisel SH; Gelenberg AJ; Growdon JH; Wurtman RJ
    Adv Biochem Psychopharmacol; 1980; 24():463-70. PubMed ID: 6996444
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium valproate in tardive dyskinesia.
    Casey DE; Hammerstad JP
    J Clin Psychiatry; 1979 Nov; 40(11):483-5. PubMed ID: 385585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral choline administration to patients with tardive dyskinesia.
    Growdon JH; Hirsch MJ; Wurtman RJ; Wiener W
    N Engl J Med; 1977 Sep; 297(10):524-7. PubMed ID: 887103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable clinical response to choline in tardive dyskinesia.
    Nasrallah HA; Dunner FJ; Smith RE; McCalley-Whitters M; Sherman AD
    Psychol Med; 1984 Aug; 14(3):697-700. PubMed ID: 6387757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin precursor effects in tardive dyskinesia.
    Nasrallah HA; Smith RE; Dunner FJ; McCalley-Whitters M
    Psychopharmacology (Berl); 1982; 77(3):234-5. PubMed ID: 6812144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.